A Spanish vaccine can be resolved against tuberculosis in 2028 in 2028

at the moment There is only a vaccine against tuberculosis, which is the most fatal diseases in the worldAnd it is more than 100 years old; In 2028, it can be replaced by Spanish, which has proven to be 50 % more effective in children and it will also be the only for adults, but it needs 22 million additional investments.
This was mentioned by a researcher at the University of Zarzza Martin and CEO of Biofabri, Esteban Rodriguez, in an interview with the media after his participation in a day organized by the Ministry of Health for the progress of his province, MTBVAC, who joined more than 25 years.
MTBVAC has started to crystallize, in The nineties, when multi -weighted tuberculosis was launched in Malaga The decisive path gave Martin, a microbiologist formed at the Pasteur Institute.
Today, clinical trials are already in their final stages, on 3 newborn and 2B children for adults, and assumptions as a large candidate – among the three who are also in the advanced stages of event studies in the world – to replace BCG (Bacillus of Calmette and Guérin), which began to manufacture in 1920.
More than 4000 children were immunized
The main difference that separates him with his centennial predecessor is that BCG It only protects the child from the widespread, and most dangerous shapes, but it is inaccurate in adolescents and adultsAnd it is one that develops tuberculosis in the respiratory or pulmonary system, the most common and continuous.
Since 2022, the clinical experience in South Africa, Senegal and Madagascar began, more than 4,000 newborns have been vaccinated in one day with MTBVAC. The idea is to reach 7500, for which they calculate two years, in addition to two others of follow -up.
The researcher says: “The vaccine is safe and immune in the past formerly a tuberculosis, but the results of the 2A stage have not been published.” The vaccine is safe and immune in tuberculosis previously, but the results of the 2A stage confirm that “the vaccine is safe and immune in tuberculosis previously.” In India, stage 3 is about to start about 30,000 adults and adolescents.
“If things go well,” says his partner for 2028 is the date he put on the horizon. So that your vaccine exceeded all regulatory procedures, which allow its marketing in 2029.